BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...

November 07, 2023 | News

Thirty-One mRNA Leaders Launch First Global Organization Dedicated to Advancing mRNA Medicines

31 biotechnology, biopharma and life science companies and educational institutions at the forefront of mRNA and next-generation encoding RNA therapeutics ...

November 02, 2023 | News

GC Aesthetics and Bimini Health Tech Join Forces for Global Breast Reconstruction Solutions

This strategic collaboration combines GC Aesthetics' 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with...

October 27, 2023 | News

Merck Validation Lab: An Inside Look with Mr. Ramesh Raju, Head of Operations BioReliance Validation Services

In an exclusive interview with BioPharma APAC, Mr. Ramesh Raju, Head of Operations for BioReliance Validation Services at Merck Validation Lab, sheds light...

October 24, 2023 | News

FDA Approves PENBRAYA™: First Vaccine for 5 Common Meningococcal Serogroups in Teens

PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...

October 23, 2023 | News

Thermo Fisher Scientific Acquires Next-Gen Proteomics Leader Olink

Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing...

October 18, 2023 | News

Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...

October 16, 2023 | News

Nona Biosciences and INGENIA Therapeutics Join Forces for Immunology Breakthroughs

By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...

October 16, 2023 | News

Metabolon Introduces Liver and Kidney Panels for Disease Research

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

October 13, 2023 | News

Simplifying Drug Discovery: How Molecule AI's Empowers Researchers - An Interview with Molecule AI's Saurabh Singal

In an illuminating interview with BioPharma APAC, Saurabh Singal, the CEO-Founder of Molecule AI, delves into the transformative power of Molecule AI's pla...

October 12, 2023 | News

Smith+Nephew Unveils Innovative Surgical Training Center in Munich

S+N Academy Munich, situated in Kustermann Park in the heart of the city, will provide a central European hub for surgeons from across Europe, the&nbs...

October 12, 2023 | News

Suvoda Enhances IRT for Precise Clinical Trial Drug Supply

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...

October 12, 2023 | News

LGC Acquires Virusys Corp, Expanding Infectious Disease Portfolio

Virusys’ monoclonal antibody technologies and virology expertise are highly complementary to LGC Clinical Diagnostics’ existing antigen product...

October 10, 2023 | News

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

October 10, 2023 | News

Stay Connected